Exact Mass: 707.3798

Fumonisin C1

PHODA-PS

1-hexadecanoyl-2-(9-hydroxy-12-oxo-10E-dodecenoyl)-sn-glycero-3-phosphoserine

Narlaprevir

C36H61N5O7S (707.4291)

C471 - Enzyme Inhibitor > C783 - Protease Inhibitor

Bietaserpine

Yohimban-16-carboxylicacid,1-[2-(diethylamino)ethyl]-11,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-,methyl ester, (3b,16b,17a,18b,20a)-

C39H53N3O9 (707.3782)

C - Cardiovascular system > C02 - Antihypertensives > C02A - Antiadrenergic agents, centrally acting > C02AA - Rauwolfia alkaloids C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

(1R,5S)-3-[2-[[1-(tert-butylsulfonylmethyl)cyclohexyl]carbamoylamino]-3,3-dimethylbutanoyl]-N-[1-(cyclopropylamino)-1,2-dioxoheptan-3-yl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide

C36H61N5O7S (707.4291)

Leucensomycin

C36H53NO13 (707.3517)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000890 - Anti-Infective Agents > D000935 - Antifungal Agents

2-amino-3-[[3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]-2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid

SHexCer 29:2;2O

SHexCer 17:1;2O/12:1

SHexCer 16:1;2O/13:1

SHexCer 15:1;2O/14:1

(2S)-2-amino-3-[[2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

(2S)-2-amino-3-[[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-[(9E,12E)-pentadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

(1R,15S,17R,18R,19S,20S)-3-[2-(diethylamino)ethyl]-6,18-dimethoxy-17-[oxo-(3,4,5-trimethoxyphenyl)methoxy]-11,12,14,15,16,17,18,19,20,21-decahydro-1H-yohimban-19-carboxylic acid methyl ester

C39H53N3O9 (707.3782)

PC 18:4/12:3;O

PC 20:4/9:4;O2

PC 22:4/8:3;O

PC 22:5/7:3;O2

PC 22:6/7:2;O2

PC 22:6/8:1;O

PC 29:8;O2

PC 30:7;O

LNAPE 33:7;O

PE 20:4/13:3;O

PE 20:5/12:3;O2

PE 22:5/11:2;O

PE 32:8;O2

PE 33:7;O

LNAPS 30:8;O

C36H54NO11P (707.3434)

LNAPS 31:7

PS O-16:0/12:3;O3

PS O-20:0/8:3;O3

PS O-28:3;O3

PS P-16:0/12:2;O3

PS P-20:0/8:2;O3

PS 16:0/11:3;O3

PS 16:0/12:2;O2

PS 20:0/7:3;O3

PS 20:0/8:2;O2

PS 20:1/7:2;O3

PS 20:1/8:1;O2

PS 22:5/8:3;O

C36H54NO11P (707.3434)

PS 27:3;O3

PS 30:8;O

C36H54NO11P (707.3434)

SHexCer 28:3;O3

C34H61NO12S (707.3914)

SHexCer 29:2;O2

ST 28:5;O8;HexNAc

C36H53NO13 (707.3517)

ST 29:4;O7;HexNAc

C37H57NO12 (707.3881)

2-(2-{[(5r,6r,7s,9s,11r,16r,18s)-19-amino-6-[(3,4-dicarboxybutanoyl)oxy]-11,16,18-trihydroxy-5,9-dimethylnonadecan-7-yl]oxy}-2-oxoethyl)butanedioic acid

(2s)-5-(n,3-dihydroxy-2-{[(2s)-1-hydroxy-5-(n-hydroxyformamido)-2-(methylamino)pentylidene]amino}propanamido)-n-{2-hydroxy-1-[(2-hydroxy-1-{[(3r)-1-hydroxy-2-oxopiperidin-3-yl]-c-hydroxycarbonimidoyl}ethyl)-c-hydroxycarbonimidoyl]ethyl}-2-(methylamino)pentanimidic acid

(2s)-5-(n,3-dihydroxy-2-{[(2s)-1-hydroxy-5-(n-hydroxyformamido)-2-(methylamino)pentylidene]amino}propanamido)-n-{2-hydroxy-1-[(2-hydroxy-1-{[(3r)-1-hydroxy-2-oxopiperidin-3-yl]-c-hydroxycarbonimidoyl}ethyl)-c-hydroxycarbonimidoyl]ethyl}-2-(methylamino)pentanimidic acid

C27H49N9O13 (707.345)

2-[2-({18-amino-6-[(3,4-dicarboxybutanoyl)oxy]-10,15,17-trihydroxy-5,8-dimethylnonadecan-7-yl}oxy)-2-oxoethyl]butanedioic acid

2-[2-({19-amino-6-[(3,4-dicarboxybutanoyl)oxy]-11,16,18-trihydroxy-5,9-dimethylnonadecan-7-yl}oxy)-2-oxoethyl]butanedioic acid

5-(n,3-dihydroxy-2-{[1-hydroxy-5-(n-hydroxyformamido)-2-(methylamino)pentylidene]amino}propanamido)-n-[2-hydroxy-1-({2-hydroxy-1-[(1-hydroxy-2-oxopiperidin-3-yl)-c-hydroxycarbonimidoyl]ethyl}-c-hydroxycarbonimidoyl)ethyl]-2-(methylamino)pentanimidic acid

5-(n,3-dihydroxy-2-{[1-hydroxy-5-(n-hydroxyformamido)-2-(methylamino)pentylidene]amino}propanamido)-n-[2-hydroxy-1-({2-hydroxy-1-[(1-hydroxy-2-oxopiperidin-3-yl)-c-hydroxycarbonimidoyl]ethyl}-c-hydroxycarbonimidoyl)ethyl]-2-(methylamino)pentanimidic acid

C27H49N9O13 (707.345)

[(2r,3s,4s,5r,6s)-6-{[(2s,3r,4r,5r,6s)-2-{[(10r)-3,10-dihydroxy-8-[(2s)-2-methylbutanoyl]-1,4,8-triazacyclotridec-3-en-1-yl]oxy}-4,5-dihydroxy-6-methyloxan-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl (2s)-2-methylbutanoate

[(2r,3s,4s,5r,6s)-6-{[(2s,3r,4r,5r,6s)-2-{[(10r)-3,10-dihydroxy-8-[(2s)-2-methylbutanoyl]-1,4,8-triazacyclotridec-3-en-1-yl]oxy}-4,5-dihydroxy-6-methyloxan-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl (2s)-2-methylbutanoate

C32H57N3O14 (707.384)

(2s)-2-(2-{[(5r,6r,7s,8s,10r,15r,17s,18s)-18-amino-6-{[(3s)-3,4-dicarboxybutanoyl]oxy}-10,15,17-trihydroxy-5,8-dimethylnonadecan-7-yl]oxy}-2-oxoethyl)butanedioic acid

2-[2-({19-amino-6-[(3,4-dicarboxybutanoyl)oxy]-11,17,18-trihydroxy-5,9-dimethylnonadecan-7-yl}oxy)-2-oxoethyl]butanedioic acid